Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2014 Aug 26;5:198. doi: 10.3389/fphar.2014.00198

Spontaneous recovery of cochlear fibrocytes after severe degeneration caused by acute energy failure

Kunio Mizutari 1,*
PMCID: PMC4143613  PMID: 25206337

Abstract

Cochlear fibrocytes in the lateral wall region play a critical role in the regulation of inner ear ion and fluid homeostasis, although these are non-sensory cells. Along with other non-sensory cells, fibrocytes in the spiral ligament have been reported to repopulate themselves after damage. However, the studies of regeneration of cochlear fibrocytes have been difficult because a suitable fibrocyte-specific degeneration model did not exist. Therefore, we analyzed cochlear fibrocytes using a rat model of acute cochlear energy failure induced by a mitochondrial toxin. This model is unique because hearing loss is caused by apoptosis of fibrocytes in the cochlear lateral wall not by damage to sensory cells. Although this model involves severe damage to the cochlear lateral wall, delayed spontaneous regeneration occurs without any treatment. Moreover, partial hearing recovery is accompanied by morphological remodeling of the cochlear lateral wall. Two hypotheses are conceivable regarding this spontaneous recovery of cochlear fibrocytes. One is that residual cochlear fibrocytes proliferate spontaneously, followed by remodeling of the functional region of the lateral wall. Another is that some foreign cells such as bone marrow-derived cells promote morphological and functional recovery of the lateral wall. Acceleration of the lateral wall recovery promoted by these mechanisms may be a new therapeutic strategy against hearing loss.

Keywords: regeneration, cochlear lateral wall, fibrocyte, 3-nitropropionic acid (3-NP), endocochlear potential, delayed hearing recovery, acute energy failure

INTRODUCTION

Hearing loss is one of the most common disabilities in the world, particularly in aged populations, and its prevalence is increasing. In the United States, 35% of individuals between 65 and 79 years old report hearing impairment; among those aged ≥80, the corresponding figure is 53% (Caban et al., 2005). Moreover, acute sensorineural hearing loss, such as sudden deafness, is a huge social problem because these diseases may occur at a younger age without any warning signs. Several etiological theories have been proposed regarding sudden deafness, such as cochlear ischemia (Seidman et al., 1999) or viral infection (Tucci, 2000). However, the etiology of these diseases remains unknown. In general, sensorineural hearing loss is irreversible once it has occurred because the loss of sensory hair cells and neurons is permanent in the mature mammalian cochlea (Kwan et al., 2009).

In addition to sensory cells, such as hair cells or spiral ganglion cells, non-sensory cells are very important to receive sound signals. For example, marginal, intermediate, and basal cells in the stria vascularis are important to maintain cochlear ion environment. Cochlear fibrocytes also play a critical role in the regulation of the inner ear ion and fluid homeostasis (Minowa et al., 1999; Delprat et al., 2005), although these are non-sensory cells. Cochlear fibrocytes of the spiral ligament contain Na+/K+-ATPase and Na+/K+/Cl- cotransporters. These molecules are essential for ionic homeostasis and maintenance of the endocochlear potential (Schulte and Adams, 1989; Spicer and Schulte, 1996; Crouch et al., 1997; Adachi et al., 2013). Gap junctions also express between and among cochlear cells including fibrocytes. Gap junctions make recycling endolymphatic potassium ions pass through these cells, therefore gap junctions are also critical for maintenance of the endocochlear potential (Kikuchi et al., 1995). Apoptosis in the cochlear lateral wall is observed in an experimental model that involves aminoglycoside-induced hearing loss (Labbe et al., 2005) and in a presbyacusis model (Alam et al., 2001), where the hearing loss is mainly caused by damage to sensory cells. Degeneration of the lateral wall fibrocytes leads to hearing loss because of a decrease in the endocochlear potential (Gratton et al., 1996, 1997; Schmiedt et al., 2002).

It was also reported that fibrocytes in the spiral ligament are capable of repopulation after damage by noise or a drug (Roberson and Rubel, 1994; Yamashita et al., 1999; Hirose and Liberman, 2003; Lang et al., 2003). Under normal conditions, cochlear fibrocytes can continue to divide even when the animal is at an advanced age (Lang et al., 2003). On the other hand, the contribution of cochlear fibrocyte repopulation to hearing recovery is still unknown because there are no suitable experimental models that can help to evaluate the influence of the cochlear lateral wall on hearing loss.

ACUTE ENERGY FAILURE IN THE INNER EAR AS A RESULT OF MITOCHONDRIAL INHIBITION

Hoya et al. (2004) reported a unique model of hearing loss in rats that involves mitochondrial inhibition in the inner ear. They used 3-nitropropionic acid (3-NP), which is an irreversible inhibitor of succinate dehydrogenase, a complex II enzyme of the mitochondrial electron transport chain (Alston et al., 1977; Coles et al., 1979). 3-NP was administered into the round window niche to inhibit ATP synthesis in the inner ear. This method of ATP deprivation in the inner ear is considered to replicate inner ear ischemia. Among several proposed etiologies of sudden deafness, inner ear ischemia is an important theory of the cause of this disease. In the detailed morphological and physiological studies of this model of hearing loss (Hoya et al., 2004; Okamoto et al., 2005; Mizutari et al., 2008), the main cause of hearing loss appears to be the loss of fibrocytes in the cochlear lateral wall, particularly in the spiral ligament. Degeneration of cochlear lateral wall fibrocytes is induced by apoptosis, and cochlear sensory cells, such as hair cells or spiral ganglion cells, survived even after severe hearing loss occurred (Mizutari et al., 2008). Another research group reported that 3-NP-induced hearing loss primarily occurs via a reduction of the endocochlear potential, along with a significant loss of spiral ligament fibrocytes (Kada et al., 2009).

This approach can cause severe and selective damage to fibrocytes in the cochlea without severe degeneration of sensory cells (Okamoto et al., 2005). Therefore, this animal model is considered to be an ideal platform for exploration of the morphological and functional prognosis of damaged cochlear fibrocytes.

SPONTANEOUS RECOVERY OF FIBROCYTES IN THE COCHLEAR LATERAL WALL AFTER SEVERE DAMAGE

A recent study revealed that cochlear fibrocytes in the lateral wall can repopulate themselves after severe 3-NP-induced degenerative changes accompanied with profound hearing loss (Mizutari et al., 2011). This cochlear lateral wall remodeling is observed in the late phase, accompanied by partial hearing recovery. In general, sensorineural hearing loss, as a result of cochlear damage, is permanent after the acute phase. Therefore, studies of hearing protection from cochlear damage usually have been performed in the early phase or before cochlear damage. However, Mizutari et al. (2011) showed that delayed hearing recovery starts 2 months after the onset of hearing loss. Moreover, an increase of Na+/K+/ATPase-β1 expression and cell proliferation was proven by an experiment with 5-bromo-2-deoxyuridine (BrdU). This type of delayed recovery of hearing is occasionally observed during treatment of sudden deafness in the clinic (Yeo et al., 2007).

Hearing recovery in the late phase in patients with sudden deafness is rarely detected, even if it occurs. The mechanism of clinical recovery of hearing remains unknown, but clinical course of the delayed recovery of hearing is similar to that involved in 3-NP-induced hearing loss. At least the spontaneous regeneration of hair cells or spiral ganglion cells never occurs because a loss of sensory cells is irreversible in mammals once these cells are gone (Kwan et al., 2009). Therefore, regeneration of non-sensory cells should play an important role in the reversal of this pathophysiology. Reduction of the endocochlear potential is promoted by disruption of cochlear blood flow, and this process is believed to be a cause of acute hearing loss (Shi, 2011). It is possible that a certain percentage of sudden deafness cases with delayed recovery of hearing is caused by an endocochlear potential reduction driven by fibrocyte dysfunction.

THE MECHANISM OF FUNCTIONAL RECOVERY OF LATERAL WALL FIBROCYTES

Several mechanisms of lateral wall regeneration have been proposed. One is local proliferation of the fibrocytes that can survive the damage. It is reported that cochlear fibrocytes can continue to divide, although the proliferation capacity is reduced when the animal is at an advanced age (Lang et al., 2003). Moreover, Lang et al. (2003) reported that the proliferation capacity is increased after the cochlear lateral wall is damaged by furosemide. It is possible that is the main mechanism of the lateral-wall remodeling after damage. However, the self-renewal ability of cochlear fibrocytes appears to be unreliable for remodeling of all structures of the lateral wall when the loss of fibrocytes is severe.

An additional hypothesis is that some substance that migrates into the cochlear lateral wall accelerates the regeneration of fibrocytes. Several studies demonstrated that the spiral ligament contains bone marrow-derived cells that can differentiate into macrophages in a deafened cochlea after acoustic trauma (Hirose et al., 2005; Tan et al., 2008). Other reports showed that macrophages migrating into an injured site perform an important function in promoting regeneration after injury in various tissues such as retinal ganglion cells (Lorber et al., 2005), dorsal root ganglion cells, and cortical neurons (Gensel et al., 2009). A transplant of mesenchymal stem cells (MSCs) into a 3-NP-damaged cochlea promotes hearing recovery (Kamiya et al., 2007). In addition, the latter report showed that the main mechanism of fibrocyte repair is acceleration of fibrocyte regeneration driven by transplanted MSCs (Kamiya et al., 2007).

Therefore, acceleration of fibrocyte repopulation is believed to be a promising therapeutic strategy for treating some types of sensorineural hearing loss. Further research is expected to reveal the detailed mechanism behind the hearing recovery via fibrocyte regeneration.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

REFERENCES

  1. Adachi N., Yoshida T., Nin F., Ogata G., Yamaguchi S., Suzuki T., et al. (2013). The mechanism underlying maintenance of the endocochlear potential by the K+ transport system in fibrocytes of the inner ear. J. Physiol. 591 4459–4472 10.1113/jphysiol.2013.258046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alam S. A., Oshima T., Suzuki M., Kawase T., Takasaka T., Ikeda K. (2001). The expression of apoptosis-related proteins in the aged cochlea of Mongolian gerbils. Laryngoscope 111 528–534 10.1097/00005537-200103000-00026 [DOI] [PubMed] [Google Scholar]
  3. Alston T. A., Mela L., Bright H. J. (1977). 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 74 3767–3771 10.1073/pnas.74.9.3767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caban A. J., Lee D. J., Gomez-Marin O., Lam B. L., Zheng D. D. (2005). Prevalence of concurrent hearing and visual impairment in US adults: the National Health Interview Survey, 1997-2002. Am. J. Public Health 95 1940–1942 10.2105/AJPH.2004.056671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coles C. J., Edmondson D. E., Singer T. P. (1979). Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 254 5161–5167 [PubMed] [Google Scholar]
  6. Crouch J. J., Sakaguchi N., Lytle C., Schulte B. A. (1997). Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear. J. Histochem. Cytochem. 45 773–778 10.1177/002215549704500601 [DOI] [PubMed] [Google Scholar]
  7. Delprat B., Ruel J., Guitton M. J., Hamard G., Lenoir M., Pujol R., et al. (2005). Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin. Mol. Cell. Biol. 25 847–853 10.1128/MCB.25.2.847-853.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gensel J. C., Nakamura S., Guan Z., Van Rooijen N., Ankeny D. P., Popovich P. G. (2009). Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 29 3956–3968 10.1523/JNEUROSCI.3992-08.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gratton M. A., Schmiedt R. A., Schulte B. A. (1996). Age-related decreases in endocochlear potential are associated with vascular abnormalities in the stria vascularis. Hear. Res. 102 181–190 10.1016/S0378-5955(96)90017-9 [DOI] [PubMed] [Google Scholar]
  10. Gratton M. A., Smyth B. J., Lam C. F., Boettcher F. A., Schmiedt R. A. (1997). Decline in the endocochlear potential corresponds to decreased Na,K-ATPase activity in the lateral wall of quiet-aged gerbils. Hear. Res. 108 9–16 10.1016/S0378-5955(97)00034-8 [DOI] [PubMed] [Google Scholar]
  11. Hirose K., Discolo C. M., Keasler J. R., Ransohoff R. (2005). Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J. Comp. Neurol. 489 180–194 10.1002/cne.20619 [DOI] [PubMed] [Google Scholar]
  12. Hirose K., Liberman M. C. (2003). Lateral wall histopathology and endocochlear potential in the noise-damaged mouse cochlea. J. Assoc. Res. Otolaryngol. 4 339–352 10.1007/s10162-002-3036-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoya N., Okamoto Y., Kamiya K., Fujii M., Matsunaga T. (2004). A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 15 1597–1600 10.1097/01.wnr.0000133226.94662.80 [DOI] [PubMed] [Google Scholar]
  14. Kada S., Nakagawa T., Ito J. (2009). A mouse model for degeneration of the spiral ligament. J. Assoc. Res. Otolaryngol. 10 161–172 10.1007/s10162-008-0147-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kamiya K., Fujinami Y., Hoya N., Okamoto Y., Kouike H., Komatsuzaki R., et al. (2007). Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. Am. J. Pathol. 171 214–226 10.2353/ajpath.2007.060948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kikuchi T., Kimura R. S., Paul D. L., Adams J. C. (1995). Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat. Embryol. (Berl.) 191 101–118 10.1007/BF00186783 [DOI] [PubMed] [Google Scholar]
  17. Kwan T., White P. M., Segil N. (2009). Development and regeneration of the inner ear. Ann. N. Y. Acad. Sci. 1170 28–33 10.1111/j.1749-6632.2009.04484.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Labbe D., Teranishi M. A., Hess A., Bloch W., Michel O. (2005). Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Hear. Res. 202 21–27 10.1016/j.heares.2004.10.002 [DOI] [PubMed] [Google Scholar]
  19. Lang H., Schulte B. A., Schmiedt R. A. (2003). Effects of chronic furosemide treatment and age on cell division in the adult gerbil inner ear. J. Assoc. Res. Otolaryngol. 4 164–175 10.1007/s10162-002-2056-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lorber B., Berry M., Logan A. (2005). Lens injury stimulates adult mouse retinal ganglion cell axon regeneration via both macrophage- and lens-derived factors. Eur. J. Neurosci. 21 2029–2034 10.1111/j.1460-9568.2005.04034.x [DOI] [PubMed] [Google Scholar]
  21. Minowa O., Ikeda K., Sugitani Y., Oshima T., Nakai S., Katori Y., et al. (1999). Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science 285 1408–1411 10.1126/science.285.5432.1408 [DOI] [PubMed] [Google Scholar]
  22. Mizutari K., Matsunaga T., Kamiya K., Fujinami Y., Fujii M., Ogawa K. (2008). Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction. J. Neurosci. Res. 86 215–222 10.1002/jnr.21470 [DOI] [PubMed] [Google Scholar]
  23. Mizutari K., Nakagawa S., Mutai H., Fujii M., Ogawa K., Matsunaga T. (2011). Late-phase recovery in the cochlear lateral wall following severe degeneration by acute energy failure. Brain Res. 1419 1–11 10.1016/j.brainres.2011.08.062 [DOI] [PubMed] [Google Scholar]
  24. Okamoto Y., Hoya N., Kamiya K., Fujii M., Ogawa K., Matsunaga T. (2005). Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. Audiol. Neurootol. 10 220–233 10.1159/000084843 [DOI] [PubMed] [Google Scholar]
  25. Roberson D. W., Rubel E. W. (1994). Cell division in the gerbil cochlea after acoustic trauma. Am. J. Otol. 15 28–34 [PubMed] [Google Scholar]
  26. Schmiedt R. A., Lang H., Okamura H. O., Schulte B. A. (2002). Effects of furosemide applied chronically to the round window: a model of metabolic presbyacusis. J. Neurosci. 22 9643–9650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schulte B. A., Adams J. C. (1989). Distribution of immunoreactive Na+,K+-ATPase in gerbil cochlea. J. Histochem. Cytochem. 37 127–134 10.1177/37.2.2536055 [DOI] [PubMed] [Google Scholar]
  28. Seidman M. D., Quirk W. S., Shirwany N. A. (1999). Mechanisms of alterations in the microcirculation of the cochlea. Ann. N. Y. Acad. Sci. 884 226–232 10.1111/j.1749-6632.1999.tb08644.x [DOI] [PubMed] [Google Scholar]
  29. Shi X. (2011). Physiopathology of the cochlear microcirculation. Hear. Res. 282 10–24 10.1016/j.heares.2011.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Spicer S. S., Schulte B. A. (1996). The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear. Res. 100 80–100 10.1016/0378-5955(96)00106-2 [DOI] [PubMed] [Google Scholar]
  31. Tan B. T., Lee M. M., Ruan R. (2008). Bone-marrow-derived cells that home to acoustic deafened cochlea preserved their hematopoietic identity. J. Comp. Neurol. 509 167–179 10.1002/cne.21729 [DOI] [PubMed] [Google Scholar]
  32. Tucci D. L. (2000). Sudden sensorineural hearing loss: a viral etiology? Arch. Otolaryngol. Head Neck Surg. 126 1164–1165 10.1001/archotol.126.9.1164 [DOI] [PubMed] [Google Scholar]
  33. Yamashita H., Shimogori H., Sugahara K., Takahashi M. (1999). Cell proliferation in spiral ligament of mouse cochlea damaged by dihydrostreptomycin sulfate. Acta Otolaryngol. 119 322–325 10.1080/00016489950181323 [DOI] [PubMed] [Google Scholar]
  34. Yeo S. W., Lee D. H., Jun B. C., Park S. Y., Park Y. S. (2007). Hearing outcome of sudden sensorineural hearing loss: long-term follow-up. Otolaryngol. Head Neck Surg. 136 221–224 10.1016/j.otohns.2006.10.021 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES